Skip to main content
logo
AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
5.63
-0.14 (-2.43%)
At close: Oct 28, 2025, 4:00 PM EDT
5.62
-0.01 (-0.18%)
Pre-market: Oct 29, 2025, 4:47 AM EDT

AbCellera Biologics Revenue

AbCellera Biologics had revenue of $17.08M in the quarter ending June 30, 2025, with 133.29% growth. This brings the company's revenue in the last twelve months to $32.88M, down -0.54% year-over-year. In the year 2024, AbCellera Biologics had annual revenue of $28.83M, down -24.17%.

Revenue (ttm)
$32.88M
Revenue Growth
-0.54%
P/S Ratio
50.80
Revenue / Employee
$55,161
Employees
596
Market Cap
1.68B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202428.83M-9.19M-24.17%
Dec 31, 202338.03M-447.40M-92.17%
Dec 31, 2022485.42M110.22M29.38%
Dec 31, 2021375.20M142.05M60.92%
Dec 31, 2020233.16M221.54M1,907.88%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

ABCL News

More News